homefeedbacksupportlog on 20-Jul-2008 
  About F1000

 What is F1000 Biology?
 Key features
 How it's organized
 FAQs
 Faculties and sections
 Scope of sections
 List of Faculty Members
 The evaluation system
 Citing F1000
 Take a tour of the site
 Accessing fulltexts
 PubMed linkout
 How to subscribe
 Academic subscriptions
 Corporate subscriptions
 Try F1000 for free
 Who we are
 Media information
 Librarian resources
 Press releases
 In the press
 Developing countries
 F1000 Medicine
 Terms and conditions
 Privacy policy
 Contact us


Douglas Yee
University of Minnesota Cancer Center, United States of America

Faculty Member: PHARMACOLOGY & DRUG DISCOVERY > Cancer therapeutics [ since 6 August 2007 ]
[ Evaluations ]
to email [Help]
Evaluations

Tamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classic estrogen receptor genomic function.
Massarweh S, Osborne CK, …, Rimawi M, Schiff R
Cancer Res 2008 Feb 1 68(3):826-33 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Douglas Yee
Evaluated 15 Feb 2008

The value meal: how to save $1,700 per month or more on lapatinib.
Ratain MJ, Cohen EE
J Clin Oncol 2007 Aug 10 25(23):3397-8 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Douglas Yee
Evaluated 29 Aug 2007

^Top  Back to Faculty Members



© 1999-2008 Biology Reports Ltd unless otherwise stated < info@f1000.com >   Terms and conditions   Legal info